Ingle JN - Search Results

1

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.

Ingle JN, Tu D, Pater JL, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Goss PE. Ingle JN, et al. Breast Cancer Res Treat. 2006 Oct;99(3):295-300. doi: 10.1007/s10549-006-9207-y. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541302 Clinical Trial.

2

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.

Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, Wold LE. Perez EA, et al. Among authors: ingle jn. Mayo Clin Proc. 2002 Feb;77(2):148-54. doi: 10.4065/77.2.148. Mayo Clin Proc. 2002. PMID: 11838648

3

Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova NSh, Mikhailov SN, Ingle JN, Spelsberg TC. Reinholz GG, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2002 Feb;71(3):257-68. doi: 10.1023/a:1014418017382. Breast Cancer Res Treat. 2002. PMID: 12002344

4

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.

Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Roche PC, et al. Among authors: ingle jn. J Natl Cancer Inst. 2002 Jun 5;94(11):855-7. doi: 10.1093/jnci/94.11.855. J Natl Cancer Inst. 2002. PMID: 12048274

5

Estrogen as therapy for breast cancer.

Ingle JN. Ingle JN. Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15. Breast Cancer Res. 2002. PMID: 12100736 Free PMC article.

6

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. Winer EP, et al. Among authors: ingle jn. J Clin Oncol. 2002 Aug 1;20(15):3317-27. doi: 10.1200/JCO.2002.06.020. J Clin Oncol. 2002. PMID: 12149306 Review.

7

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC. Reinholz MM, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2002 Jun;74(3):255-69. doi: 10.1023/a:1016339120506. Breast Cancer Res Treat. 2002. PMID: 12206515

8

Sequencing of hormonal therapy in breast cancer.

Ingle JN. Ingle JN. Breast J. 2002 Nov-Dec;8(6):332-7. doi: 10.1046/j.1524-4741.2002.08602.x. Breast J. 2002. PMID: 12390355 Review.

9

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

Come SE, Buzdar AU, Arteaga CL, Brodie AM, Davidson NE, Dowsett M, Ingle JN, Johnston SR, Lee AV, Osborne CK, Pritchard KI, Vogel VG, Winer EP, Hart CS. Come SE, et al. Among authors: ingle jn. Clin Cancer Res. 2003 Jan;9(1 Pt 2):443S-6S. Clin Cancer Res. 2003. PMID: 12538498 Review. No abstract available.

10

Adjuvant endocrine therapy in postmenopausal breast cancer.

Ingle JN. Ingle JN. Clin Cancer Res. 2003 Jan;9(1 Pt 2):480S-5S. Clin Cancer Res. 2003. PMID: 12538504 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page